The Veterinary Vaccines Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Increase in Zoonotic Diseases
The number, frequency, and variety of zoonotic disease outbreaks have increased dramatically during the last century. These occurrences, which are caused by infections spilling from animal hosts to humans, may have increased by more than thrice in the previous decade, with the incidence of novel zoonotic illnesses infecting humans quadrupling within the same time period. Currently, zoonotic illnesses account for 60% of all new infectious diseases in humans. Animal viruses can infect people directly or indirectly, depending on whether they come into touch with wild or farmed animals. These intermediary hosts function as mixing vessels, allowing diseases to evolve genetically and infect humans. And, in recent times, human-to-animal interaction has expanded substantially, increasing the potential of zoonotic disease epidemics. Growing zoonotic diseases has boosted the demand for veterinary vaccines globally.
DNA Vaccine Represents New Frontier In Vaccine Technology
Vaccines based on DNA represent a new frontier in vaccine technology. This technique has a significant use in the veterinary field. DNA vaccines have already made inroads into several areas of veterinary medicine. However, while creating DNA vaccines for animals, numerous critical concerns must be addressed, including whether the vaccine is efficacious and cost effective in comparison to already available alternatives. Another key topic to address is how to utilise this new technology in a variety of scenarios, from the domestic pet to individual fish in fisheries with thousands of animals, to wildlife disease management programmes. In certain situations, DNA vaccines offer an intriguing alternative for immunisation, but in others, the current methods are not enough. A variety of veterinary diseases and the development being made using DNA vaccine technology. Moreover, DNA vaccines can be used for simultaneous immunizations against many pathogens and are relatively less expensive to manufacture and store. Hence, in near future DNA vaccines are expected to witness a significant growth.
What Are These Questions You Should Ask Before Buying A Market Research Report?
• How is the veterinary vaccines market evolving?
• What is driving and restraining the veterinary vaccines market?
• How each veterinary vaccines submarket segment will grow over the forecast period and how much revenue will these submarkets account for in 2032?
• How will the market shares for each veterinary vaccines submarket develop from 2022 to 2032?
• What will be the main driver for the overall market from 2022 to 2032?
• Will leading veterinary vaccines markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
• Who are the leading players and what are their prospects over the forecast period?
• What are the veterinary vaccines projects for these leading companies?
• How will the industry evolve during the period between 2022 and 2032? What are the implication of veterinary vaccines projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the veterinary vaccines market?
• Where is the veterinary vaccines market heading? And how can you ensure you are at the forefront of the market?
• What can be the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path? C-suite?
You need to discover how this will impact the veterinary vaccines market today, and over the next 10 years:
• Our 444-page report provides 310 tables and 290 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• Contains in-depth analyse of global, regional and national sales and growth
• Highlights for you the key successful trends, changes and revenue projections made by your competitors
This report tells you TODAY how the veterinary vaccines market will develop in the next 10 years, and in-line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Delivers exclusive COVID-19 variations economic data specific to your market.
Forecasts to 2032 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising veterinary vaccines prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, V, L, W and U are discussed in this report.
Global Veterinary Vaccines Market (COVID Impact Analysis) by Companion Animal
• Dogs
• Cats
Global Veterinary Vaccines Market (COVID Impact Analysis) by Technology
• Live Attenuated Vaccines
• Inactivated Vaccines
• Toxoid Vaccines
• Recombinant Vaccines
• Other Technology
Global Veterinary Vaccines Market (COVID Impact Analysis) by Type
• Porcine Vaccines
• Poultry Vaccine
• Livestock Vaccine
• Companion Animal Vaccine
• Aquaculture Vaccines
• Other Type
Global Veterinary Vaccines Market (COVID Impact Analysis) by Livestock
• Cattle
• Pigs
• Poultry
• Other Livestock
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 4 regional and 20 leading national markets:
North America Veterinary Vaccines Market, 2022 to 2032 Market Outlook
• U.S. Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• Canada Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• Mexico Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
Europe Veterinary Vaccines Market, 2022 to 2032 Market Outlook
• Germany Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• Spain Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• United Kingdom Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• France Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• Italy Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• Rest of Europe Market Forecast & COVID Impact Analysis
Asia Pacific Veterinary Vaccines Market, 2022 to 2032 Market Outlook
• China Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• Japan Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• India Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• Australia Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• South Korea Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• Rest of Asia Pacific Market Forecast & COVID Impact Analysis
LAMEA Veterinary Vaccines Market, 2022 to 2032 Market Outlook
• Brazil Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• Turkey Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• Saudi Arabia Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• South Africa Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• UAE Veterinary Vaccines Market, 2022 to 2032 Market Forecast & COVID Impact Analysis
• Rest of Latin America, Middle East and Africa
The report also includes profiles and for some of the leading companies in the Veterinary Vaccines Market, 2022 to 2032, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• Zoetis Inc.
• Virbac Pharmaceutical
• Boehringer Ingelheim Animal Health
• Elanco Animal Health Incorporated
• Intas Pharmaceuticals Ltd
• Merck Animal Health
• Indian Immunologicals Ltd (IIL)
• Phibro Animal Health Corporation (Phibro)
• Biogenesis Bago SA
• Hester Biosciences
• Hipra Pharmaceutical Company
Overall world revenue for Veterinary Vaccines Market, 2022 to 2032 in terms of value the market will surpass US$xx million in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Veterinary Vaccines Market, 2022 to 2032 Market report helps you?
In summary, our 444+ page report provides you with the following knowledge:
• Revenue forecasts for Veterinary Vaccines Market, 2022 to 2032 Market include forecasts for companion animal, technology, type, livestock each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2032 for 4 regional and 20 key national markets – See forecasts for the Veterinary Vaccines Market, 2022 to 2032 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 12 of the major companies involved in the Veterinary Vaccines Market, 2022 to 2032 Market.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Veterinary Vaccines Market, 2022 to 2032 Market and leading companies. You will find data, trends and predictions.
'
1 Report Overview
1.1 Introduction to Veterinary Vaccines Market
1.2 Global Veterinary Vaccine Market Overview
1.3 What are the Objectives of this Report?
1.4 What is the Scope of the Report?
1.5 Veterinary Vaccines Market Definition
1.5.1 Vaccination
1.5.2 Veterinary Vaccines
1.6 Why You Should Read This Report
1.7 What This Report Delivers
1.8 Key Questions Answered By This Analytical Report Include:
1.9 Who is This Report for?
1.10 Research Methodology
1.11 Frequently Asked Questions (FAQs)
1.12 Associated Reports
1.13 About
2 Executive Summary
2.1 Introduction
3 Global Market Dynamics
3.1 Current Trends in the Global Market
3.1.1 The Possible Benefits Of Increasing Animal Wellbeing
3.1.2 New Vaccine Technologies to Combat Outbreak Situations
3.2 Market Driving Factors
3.2.1 Growing Interest For The Veterinary Vaccinology Community
3.2.2 Vaccination For Pet Animals Needs More Attention in Developing countries
3.2.3 The Increase In Zoonotic Diseases
3.2.4 Growing demand for Animal derived Protein
3.3 Market Restraining Factors
3.3.1 Lack of Immunization Adaptation Among Smallholder Farmers
3.3.2 The Complexity And Cost Of Vaccine Manufacturing
3.3.3 Hurdles In The Lengthy And Costly Path To A Licenced Vaccine
3.4 Opportunities in the Global Market
3.4.1 DNA Vaccine Represents New Frontier In Vaccine Technology
3.4.2 Modern Vaccine Strategies in Animal Health
3.5 Challenges in the Global Market
3.5.1 Virulent Organisms Are The Most Unambiguous Way To Measure the DOI (Minimum Duration of Immunity)
3.5.2 Highly Advanced Technology, Availability of Skilled labour and Product Recalls Makes Vaccine manufacturing a capital intensive market
3.5.3 Limited Understanding of Immune Response in Animals
3.5.4 Regulatory Approval Processes Also Have An Important Impact On The Decision
3.6 SWOT Analysis for Global Market
3.7 PEST Analysis for Global Market
3.8 Porter’s Five Forces
3.8.1 Threats of New Entrants- Medium
3.8.2 Bargaining Power of Suppliers- high
3.8.3 Bargaining Power of Buyers- High to Medium
3.8.4 Threats of Substitute - Medium
3.8.5 Rivalry Among The Existing Competitors - High
4 Global Veterinary Vaccines Market Analysis
4.1 Global Market Outlook
4.1.1 Global focus on current developments
4.1.2 Strategies to Increase Adoption Of Animal Vaccines By Smallholder Farmers With Focus On Neglected Diseases And Marginalized Populations
4.2 Global Market Size Estimation and Forecast by Value
4.2.1 Pre-COVID-19 Market Scenario
4.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
5 Global Market Size Estimation and Forecast by Region
5.1.1 Pre-COVID-19 Market Scenario
5.1.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
6 Global Veterinary Vaccines Market by Companion Animal
6.1.1 Dogs
6.1.2 Cat
6.1.3 Pre-COVID-19 Market Scenario
6.1.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
7 Global Veterinary Vaccines Market by Technology
7.1.1 Live Attenuated Vaccines
7.1.2 Inactivated Vaccines
7.1.3 Toxoid Vaccines
7.1.4 Recombinant Vaccines
7.1.5 Other Technology
7.1.5.1 Attenuated Vaccines
7.1.5.2 Subunit Vaccines
7.1.5.3 DNA vaccines
7.1.5.4 Gene-deleted Vaccines
7.1.5.5 Virus-vectored Vaccines
7.1.6 Pre-COVID-19 Market Scenario
7.1.7 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
8 Global Veterinary Vaccines Market by Type
8.1.1 Poultry Viral Vaccines
8.1.2 Porcine Viral Vaccines
8.1.3 Bovine Viral Vaccines
8.1.4 Livestock Vaccine
8.1.5 Companion Animal Vaccine
8.1.6 Aquaculture Vaccines
8.1.7 Other Type
8.1.8 Pre-COVID-19 Market Scenario
8.1.9 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
9 Global Veterinary Vaccines Market by Livestock
9.1.1 Cattle
9.1.2 Poultry
9.1.3 Fisheries
9.1.4 Other Livestock
9.1.5 Pre-COVID-19 Market Scenario
9.1.6 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10 North America Veterinary Vaccines Market Analysis
10.1 North America Market Outlook
10.1.1 Introduction
10.1.2 Boehringer Ingelheim Animal Health USA Establishes Pawru, Inc.
10.1.3 The U.S. is Planning Vaccine Bank to Guard against Foot-And-Mouth Disease
10.1.4 Pre-COVID-19 Market Scenario
10.1.5 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10.2 North America Veterinary Vaccines Market Analysis by Country
10.2.1 Pre-COVID-19 Market Scenario
10.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10.3 North America Veterinary Vaccines Market by Companion Animal
10.3.1 Pre-COVID-19 Market Scenario
10.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10.4 North America Veterinary Vaccines Market by Technology
10.4.1 Pre-COVID-19 Market Scenario
10.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10.5 North America Veterinary Vaccines Market by Type
10.5.1 Pre-COVID-19 Market Scenario
10.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10.6 North America Veterinary Vaccines Market by Livestock
10.6.1 Pre-COVID-19 Market Scenario
10.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10.7 US Veterinary Vaccines Market Analysis
10.7.1 Merck Animal Health Launches Nasalgen®
10.7.2 Zoetis Expands Vector Vaccine Portfolio With Introduction Of POULVAC® PROCERTA™ HVT-IBD
10.7.3 Pre-COVID-19 Market Scenario
10.7.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10.8 Canada Veterinary Vaccines Market Analysis
10.8.1 Ingelvac Provenza™ intranasal vaccine for Swine flu
10.8.2 ERYSENG® PARVO, a new sow reproductive vaccine launched by HIPRA in Canada
10.8.3 'Time to Vaccinate' Campaign To Empower Farmers With Knowledge
10.8.4 Pre-COVID-19 Market Scenario
10.8.5 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10.9 Mexico Veterinary Vaccines Market Analysis
10.9.1 Towards a World Free Of Dog-Transmitted Rabies
10.9.2 3-in-1 Vaccine for Poultry Launched in Mexico
10.9.3 Pre-COVID-19 Market Scenario
10.9.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11 Europe Veterinary Vaccines Market Analysis
11.1 Introduction
11.1.1 PREVEXXION® RN: the next generation of Marek’s disease vaccines now available in the EU and the UK
11.1.2 NASYM (by Hipra), the new BRSV strategy has started throughout Europe
11.1.3 Pre-COVID-19 Market Scenario
11.1.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.2 Europe Veterinary Vaccines Market by Country
11.2.1 Pre-COVID-19 Market Scenario
11.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.3 Europe Veterinary Vaccines Market by Companion Animal
11.3.1 Pre-COVID-19 Market Scenario
11.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.4 Europe Veterinary Vaccines Market by Technology
11.4.1 Pre-COVID-19 Market Scenario
11.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.5 Europe Veterinary Vaccines Market by Type
11.5.1 Pre-COVID-19 Market Scenario
11.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.6 Europe Veterinary Vaccines Market by Livestock
11.6.1 Pre-COVID-19 Market Scenario
11.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.7 Germany Veterinary Vaccines Market Analysis
11.7.1 Canine vaccination in Germany
11.7.2 Lack of owner compliance and high cost of vaccines are major deterrent for market growth
11.7.3 Pre-COVID-19 Market Scenario
11.7.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.8 UK Veterinary Vaccines Market Analysis
11.8.1 BBSRC Under The Auspices Of Global Strategic Alliances
11.8.2 BBSRC’s (Biotechnology and Biological Sciences Research Council) Current Veterinary Vaccinology Investments
11.8.3 Pre-COVID-19 Market Scenario
11.8.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.9 France Veterinary Vaccines Market Analysis
11.9.1 The Main Reason For The Spread Of HPAI Viruses In The South-Eastern Region Of France
11.9.2 Pre-COVID-19 Market Scenario
11.9.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.10 Italy Veterinary Vaccines Market Analysis
11.10.1 Vaccination In The Control Strategy Of Bluetongue In Italy
11.10.2 HIPRA presents ERAVAC®, the new vaccine against RHDV2, in Italy
11.10.3 Pre-COVID-19 Market Scenario
11.10.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.11 Spain Veterinary Vaccines Market Analysis
11.11.1 HIPRA presents two new vaccines for poultry farming in Spain
11.11.2 Pre-COVID-19 Market Scenario
11.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.12 Rest of Europe Veterinary Vaccines Market Analysis
11.12.1 National Legislation Procedures For Poultry Vaccination
11.12.2 HIPRA launches ICTHIOVAC® VR/PD (vaccine against vibriosis and pasteurellosis in sea bass) in Spain, Italy, Portugal, France and Tunisia
11.12.3 Pre-COVID-19 Market Scenario
11.12.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12 Asia-Pacific Veterinary Vaccines Market Analysis
12.1.1 Introduction
12.1.2 Rabies Control In South Asia Requires A One Health Approach
12.1.3 Lack of Awareness of Global Vaccination Practices in Asia
12.1.4 Pre-COVID-19 Market Scenario
12.1.5 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.2 Asia-Pacific Veterinary Vaccines Market by Country
12.2.1 Pre-COVID-19 Market Scenario
12.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.3 Asia-Pacific Veterinary Vaccines Market by Companion Animal
12.3.1 Pre-COVID-19 Market Scenario
12.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.4 Asia-Pacific Veterinary Vaccines Market by Technology
12.4.1 Pre-COVID-19 Market Scenario
12.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.5 Asia-Pacific Veterinary Vaccines Market by Type
12.5.1 Pre-COVID-19 Market Scenario
12.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.6 Asia-Pacific Veterinary Vaccines Market by Livestock
12.6.1 Pre-COVID-19 Market Scenario
12.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.7 China Veterinary Vaccines Market Analysis
12.7.1 Zoetis to Expand Animal Vaccine Research and Manufacturing in Suzhou, China
12.7.2 Boehringer Ingelheim Launches First Veterinary Vaccines Produced In China
12.7.3 Pre-COVID-19 Market Scenario
12.7.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.8 India Veterinary Vaccines Market Analysis
12.8.1 Indian Immunologicals Develops Vaccine to Fight Tapeworms in Pigs
12.8.2 The Vaccine Makers Eyeing US$ 1768.69 Crore Programme
12.8.3 Pre-COVID-19 Market Scenario
12.8.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.9 Japan Veterinary Vaccines Market Analysis
12.9.1 Sumitomo Corporation expands veterinary medicine sales to Indonesia through partnership with Medion Pharma
12.9.2 Japan Donates Farm Animal Vaccines
12.9.3 Pre-COVID-19 Market Scenario
12.9.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.10 South Korea Veterinary Vaccines Market Analysis
12.10.1 Strategies to Maintain Korea's Animal Rabies Non-Occurrence Status
12.10.2 Korea has Successfully Implemented A National Rabies Control Program Including Mass Vaccination
12.10.3 Pre-COVID-19 Market Scenario
12.10.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.11 Australia Veterinary Vaccines Market Analysis
12.11.1 In Australia, Over 140 Vaccinations Are Approved For Use In Cattle And Companion Animals
12.11.2 Pre-COVID-19 Market Scenario
12.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.12 Rest of Asia-Pacific Veterinary Vaccines Market Analysis
12.12.1 Growing awareness of vaccination to boost the market growth for Rest of Asia
12.12.2 Vietnam: a Sustainable Collaboration with Farmers
12.12.3 Pre-COVID-19 Market Scenario
12.12.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13 LAMEA Veterinary Vaccines Market Analysis
13.1.1 Introduction
13.1.2 Saudi-Argentine JV Plans $60 Mn Animal Vaccine Manufacturing Plant in Riyadh
13.1.3 Pre-COVID-19 Market Scenario
13.1.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.2 LAMEA Veterinary Vaccines Market by Country
13.2.1 Pre-COVID-19 Market Scenario
13.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.3 LAMEA Veterinary Vaccines Market by Companion Animal
13.3.1 Pre-COVID-19 Market Scenario
13.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.4 LAMEA Veterinary Vaccines Market by Technology
13.4.1 Pre-COVID-19 Market Scenario
13.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.5 LAMEA Veterinary Vaccines Market by Type
13.5.1 Pre-COVID-19 Market Scenario
13.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.6 LAMEA Veterinary Vaccines Market by Livestock
13.6.1 Pre-COVID-19 Market Scenario
13.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.7 Brazil Veterinary Vaccines Market Analysis
13.7.1 Use Of Collar Impregnated With Insecticide For Reducing Incidence Of Leishmania Infection in Brazil
13.7.2 Pre-COVID-19 Market Scenario
13.7.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.8 South Africa Veterinary Vaccines Market Analysis
13.8.1 Strengthening Veterinary Services in Africa
13.8.2 Pre-COVID-19 Market Scenario
13.8.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.9 Saudi Arabia Veterinary Vaccines Market Analysis
13.9.1 Pre-COVID-19 Market Scenario
13.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.10 Turkey Veterinary Vaccines Market Analysis
13.10.1 Turkey: The First Veterinary Vaccine Against Canine Leishmaniosis
13.10.2 Pre-COVID-19 Market Scenario
13.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.11 UAE Veterinary Vaccines Market Analysis
13.11.1 Abu Dhabi Campaign Aims To Improve Immunity Among Livestock
13.11.2 Dubai-Developed Covid-19 Vaccine To Protect Animals Against Virus
13.11.3 Pre-COVID-19 Market Scenario
13.11.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.12 Rest of LAMEA Veterinary Vaccines Market Analysis
13.12.1 To Increase Productivity Of Small Family Farms In Latin America
13.12.2 Pre-COVID-19 Market Scenario
13.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14 Leading Company Profiles
14.1 Growth Strategy Allows Companies to Expand Their Business
14.1.1 Growth Through Acquisitions, Expansion and Investment
14.1.2 Agreements, Contracts and Establishment
14.1.3 Strategic Alliance
14.1.4 Introduction of New Segment
14.2 Zoetis Inc.
14.2.1 Company Snapshot
14.2.2 Company Overview
14.2.3 Company Financial Profile
14.2.4 Company Product Benchmarking
14.2.5 Company Recent Developments
14.3 Virbac Pharmaceutical
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Company Financial Profile
14.3.4 Company Product Benchmarking
14.3.5 Company Recent Developments
14.4 Boehringer Ingelheim Animal Health
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Company Financial Profile
14.4.4 Company Product Benchmarking
14.4.5 Company Recent Developments
14.5 Elanco Animal Health Incorporated
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Company Financial Profile
14.5.4 Company Product Benchmarking
14.5.5 Company Recent Developments
14.6 Intas Pharmaceuticals Ltd
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Company Financial Profile
14.6.4 Company Product Benchmarking
14.6.5 Company Recent Developments
14.7 Merck Animal Health.
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Company Financial Profile
14.7.4 Company Product Benchmarking
14.7.5 Company Recent Developments
14.8 Indian Immunologicals Ltd.
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Company Financial Profile
14.8.4 Company Product Benchmarking
14.8.5 Company Recent Developments
14.9 Phibro Animal Health Corporation
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Company Financial Profile
14.9.4 Company Product Benchmarking
14.9.5 Company Recent Developments
14.10 Biogenesis Bago SA
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Company Financial Profile
14.10.4 Company Product Benchmarking
14.10.5 Company Recent Developments
14.11 Hester Biosciences
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Company Financial Profile
14.11.4 Company Product Benchmarking
14.11.5 Company Recent Developments
14.12 Hipra Pharmaceutical Company
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Company Financial Profile
14.12.4 Company Product Benchmarking
14.12.5 Company Recent Developments
15 Conclusion & Recommendation
15.1 Conclusion Summary
15.2 Recommendations
15.2.1 Duration of Immunity Should Sustain for Longer Duration
15.2.2 Incessant Vaccine Research will aid in Preventive and Prompt treatment
15.2.3 Intensive Animal Production To Fulfil Global Nutritional Needs
15.3 Leading and Fastest Growing Regions
16 Glossary Terms
List of Table
Table 1 Global Veterinary Vaccines Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 2 Global Veterinary Vaccines Market Snapshot, 2022 & 2032 (US$million, CAGR %)
Table 3 Global Recombinant Viral Vector Vaccines ( Manufacturers & Pathogen)
Table 4 Global DNA Vaccines ( Manufacturers & Pathogen)
Table 5 Global Recombinant Viral Vector Vaccines ( Manufacturers & Pathogen)
Table 6 DIVA Vaccines ( Manufacturers & Pathogen)
Table 7 Veterinary Vaccines SWOT Analysis
Table 8 Global Veterinary Vaccines Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 9 Global Veterinary Vaccines Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 10 Global Veterinary Vaccines Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 11 Global Veterinary Vaccines Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 12 Global Veterinary Vaccines Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 13 Global Veterinary Vaccines Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 14 Global Veterinary Vaccines Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 15 Global Veterinary Vaccines Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 16 Global Veterinary Vaccines Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 17 Global Veterinary Vaccines Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 18 Global Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 19 Global Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 20 Global Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 21 Global Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 22 Global Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 23 Global Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 24 Global Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 25 Global Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 26 Global Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 27 Global Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 28 Global Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 29 Global Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 30 Global Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 31 Global Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 32 Global Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 33 Global Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 34 Global Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 35 Global Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 36 Global Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 37 Global Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 38 North America Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 39 North America Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 40 North America Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 41 North America Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 42 North America Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 43 North America Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 44 North America Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 45 North America Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 46 North America Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 47 North America Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 48 North America Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 49 North America Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 50 North America Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 51 North America Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 52 North America Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 53 North America Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 54 North America Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 55 North America Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 56 North America Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 57 North America Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 58 North America Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 59 North America Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 60 North America Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 61 North America Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 62 North America Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 63 US Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 64 US Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 65 US Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 66 US Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 67 US Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 68 Canada Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 69 Canada Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 70 Canada Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 71 Canada Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 72 Canada Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 73 Mexico Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 74 Mexico Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 75 Mexico Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 76 Mexico Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 77 Mexico Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 78 Europe Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 79 Europe Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 80 Europe Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 81 Europe Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 82 Europe Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 83 Europe Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 84 Europe Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 85 Europe Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 86 Europe Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 87 Europe Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 88 Europe Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 89 Europe Veterinary Vaccines Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 90 Europe Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 91 Europe Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 92 Europe Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 93 Europe Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 94 Europe Veterinary Vaccines Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 95 Europe Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 96 Europe Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 97 Europe Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 98 Europe Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 99 Europe Veterinary Vaccines Market by Livestock, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 100 Europe Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 101 Europe Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 102 Europe Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 103 Germany Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 104 Germany Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 105 Germany Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 106 Germany Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 107 Germany Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 108 UK Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 109 UK Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 110 UK Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 111 UK Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 112 UK Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 113 France Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 114 France Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 115 France Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 116 France Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 117 France Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 118 Italy Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 119 Italy Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 120 Italy Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 121 Italy Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 122 Italy Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 123 Spain Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 124 Spain Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 125 Spain Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 126 Spain Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 127 Spain Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 128 Rest of Europe Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 129 Rest of Europe Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 130 Rest of Europe Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 131 Rest of Europe Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 132 Rest of Europe Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 133 Asia-Pacific Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 134 Asia-Pacific Veterinary Vaccines Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 135 Asia-Pacific Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 136 Asia-Pacific Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 137 Asia-Pacific Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 138 Asia-Pacific Veterinary Vaccines Market by Companion Animal, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U-Shape R
